Published in Virus Weekly, October 2nd, 2007
"Osteoprotegerin (OPG), the receptor activator of NF-kappab-ligand (RANKL), and the TNF-related...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
Source: Virus Weekly (2007-10-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.